Expression Analysis of Fibroblast Growth Factor-23, Matrix Extracellular Phosphoglycoprotein, Secreted Frizzled-Related Protein-4, and Fibroblast Growth Factor-7: Identification of Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein as Major Factors Involved in Tumor-Induced Osteomalacia
- 1 December 2008
- journal article
- case report
- Published by Elsevier BV in Endocrine Practice
- Vol. 14 (9), 1108-1114
- https://doi.org/10.4158/ep.14.9.1108
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The phosphatonins and the regulation of phosphate transport and vitamin D metabolismThe Journal of Steroid Biochemistry and Molecular Biology, 2007
- The Roles of Specific Genes Implicated as Circulating Factors Involved in Normal and Disordered Phosphate Homeostasis: Frizzled Related Protein-4, Matrix Extracellular Phosphoglycoprotein, and Fibroblast Growth Factor 23Endocrine Reviews, 2006
- Fibroblast Growth Factor 7: An Inhibitor of Phosphate Transport Derived from Oncogenic Osteomalacia-Causing TumorsJournal of Clinical Endocrinology & Metabolism, 2005
- Bone as a source of FGF23: regulation by phosphate?Bone, 2004
- Venous Sampling for Fibroblast Growth Factor-23 Confirms Preoperative Diagnosis of Tumor-Induced OsteomalaciaJournal of Clinical Endocrinology & Metabolism, 2004
- Most Osteomalacia-associated Mesenchymal Tumors Are a Single Histopathologic EntityThe American Journal of Surgical Pathology, 2004
- Localisation of mesenchymal tumours by somatostatin receptor imagingThe Lancet, 2002
- MEPE, the Gene Encoding a Tumor-Secreted Protein in Oncogenic Hypophosphatemic Osteomalacia, Is Expressed in BoneGenomics, 2001
- Tumor-induced osteomalacia and the regulation of phosphate homeostasisBone, 2000
- Inhibition of Renal Phosphate Transport by a Tumor Product in a Patient with Oncogenic OsteomalaciaThe New England Journal of Medicine, 1994